4DMedical (ASX:4DX) has revealed its execution of a reseller deal with Philips in the US to distribute the former’s products in the market.
4DMedical produces what it calls “4D” lung imaging “XV Technology,” and advertisers the world’s first dedicated lung function scanner on its website. The product ultimately allows doctors to image lungs in a fashion superior to traditional X-Ray.
Philips, for its part – you’d probably recognise the logo, it’s that Philips – is a healthcare product seller established internationally.
4DMedical expects the deal to establish a “transformative commercialisation pathway” in the world’s largest economy. Philips will have exclusive distro rights for 5 years; 4DMedical is eyeing off Philips’ existing relationships with the Veterans’ Affairs and Defence departments in the US.
Behind the scenes, 4DMedical has previously conducted research into veteran care especially where relating to burn pits, which are what they sound like. Pits are dug, clothes and other items are poured in, and often they are drenched in diesel fuel and set alight. Some soldiers must wait and confirm everything was incinerated; much smoke can be inhaled during these procedures.
They are often performed without gas masks.
“In January 2024, 4DMedical announced it had signed a Teaming Agreement with Philips to establish a strategic collaboration to advance solutions to evaluate Veterans with deployment-related respiratory disease (DRRD) and other respiratory conditions,” the company confirmed on Friday.
Management was more direct.
“Central to the collaboration between Philips and 4DMedical is a drive to address the significant health challenges faced by Veterans due to military toxic exposures,” 4DX CEO Andreas Fouras said.
“This ongoing collaboration is a pivotal strategy to provide advanced care and support for those who have bravely served.”
4DX last traded at 44.5cps.
Join the discussion: See what HotCopper users are saying about 4DMedical Ltd and be part of the conversations that move the markets.